Old Web
English
Sign In
Acemap
>
authorDetail
>
Lisa Wetherhold
Lisa Wetherhold
Janssen Pharmaceutica
Prostate cancer
Pathology
Medicine
Proteus
Placebo
2
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Computational pathological identification of prostate cancer following neoadjuvant treatment.
2020
Journal of Clinical Oncology
Belma Dogdas
Christopher Kanan
Patricia Raciti
Shaozhou Ken Tian
Sabine Brookman-May
Lisa Wetherhold
Andressa Smith
Oliver Brendan Rooney
Sharon Anne McCarthy
John Alvarez
Angela Lopez-Gitlitz
Adam Casson
Ran Godrich
Jeremy D. Kunz
Rodrigo Ceballos
Carla Leibowitz
Leo Grady
Thomas J. Fuchs
Show All
Source
Cite
Save
Citations (2)
PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC).
2019
Journal of Clinical Oncology
Mary-Ellen Taplin
Martin E. Gleave
Christopher H Evans
Eleni Efstathiou
Philip W. Kantoff
Ashley E. Ross
Neal D. Shore
Alberto Briganti
Boris Hadaschik
Axel Heidenreich
Oliver Brendan Rooney
Shaozhou Ken Tian
Lisa Wetherhold
Weichun Xu
Shinta Cheng
Sabine Brookman-May
Angela Lopez-Gitlitz
Adam S. Kibel
Show All
Source
Cite
Save
Citations (4)
1